Biofrontera AG (ETR:B8FK)
2.500
0.00 (0.00%)
At close: Jan 23, 2026
Biofrontera AG Revenue
Biofrontera AG had revenue of 3.55M EUR in the quarter ending September 30, 2025, with 1.75% growth. This brings the company's revenue in the last twelve months to 23.26M, up 7.32% year-over-year. In the year 2024, Biofrontera AG had annual revenue of 21.67M, down -32.81%.
Revenue (ttm)
23.26M
Revenue Growth
+7.32%
P/S Ratio
0.65
Revenue / Employee
306.01K
Employees
76
Market Cap
15.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.67M | -10.58M | -32.81% |
| Dec 31, 2023 | 32.25M | 6.51M | 25.29% |
| Dec 31, 2022 | 25.74M | -3.05M | -10.59% |
| Dec 31, 2021 | 28.79M | -1.56M | -5.14% |
| Dec 31, 2020 | 30.35M | -919.00K | -2.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Maternus-Kliniken Aktiengesellschaft | 116.17M |
| MeVis Medical Solutions AG | 16.64M |
| Geratherm Medical AG | 14.29M |
| aap Implantate AG | 12.16M |